Belfast medtech, Diaceutics PLC has appointed Nikita Lynn to Vice President of Finance. She has been promoted to this role following her tenure as Senior Director of Corporate Advancement.
In her new role within Diaceutics, Nikita will be responsible for the financial operations and corporate development of the company, reporting to the CFO, board of directors and non-executive directors. She brings extensive experience in financial reporting, taxation and auditing for public companies to the position.
Before joining Diaceutics in August 2020, Nikita was a Senior Manager at PwC where she spent approximately six years in the Assurance Department, working predominantly within audit. During this time, she also worked on reporting accountant engagements, which included project leading the IPO’s of Diaceutics PLC in March 2019 and Fusion Antibodies in December 2017.
RELATED: Diaceutics partners with Alva10 to improve its new diagnostic network
Nikita trained and qualified as a Chartered Accountant with the Institute of Chartered Accountants, Ireland, and is an active contributor with the Institute of Chartered Accountants Ireland, Ulster Society, having gained experience across several committee roles.
Philip White, Chief Financial Officer of Diaceutics, said: “An expert in finance, Nikita has a stellar track record and in-depth experience within the technology, pharma, and manufacturing sectors.
"During her time as Senior Director of Corporate Advancement at Diaceutics, she has demonstrated the leadership abilities which will be invaluable in helping us advance our mission and solutions enabled by DXRX – The Diagnostic Network®, and in unlocking the transformative financial value of platform business models.”
Nikita Lynn added that she is "thrilled to commence a new chapter in my Diaceutics career, and to continue working alongside a diverse group of talented professionals aligned on a common goal – to provide every patient with the treatment they deserve."
Source: Written from press release
